Pediatric Oncology

Top Story

Geneticist to lead Vanderbilt cancer center’s health disparities program

Geneticist to lead Vanderbilt cancer center’s health disparities program
June 19, 2017

Tuya Pal, MD, has been appointed associate director of cancer health disparities at Vanderbilt-Ingram Cancer Center.

Pal, a clinical geneticist, also will serve as associate professor of medicine at Vanderbilt University Medical Center School of Medicine and Ingram associate professor of cancer research.

10 highlights from the ASCO Annual Meeting

June 16, 2017
This year’s ASCO Annual Meeting, held June 2-6 in Chicago, featured the theme “Making a Difference in Cancer Care With You.” HemOnc Today
Meeting NewsVideo

VIDEO: Visiting expert program helps community providers learn about immuno-oncology

June 12, 2017
CHICAGO — Jarushka Naidoo, MBBCh, spoke with HemOnc Today at the ASCO Annual Meeting about the Institute for Clinical Immuno-Oncology. The institute, an initiative…
FDA News

FDA grants breakthrough therapy designation to burtomab for pediatric neuroblastoma

June 12, 2017
The FDA granted breakthrough therapy designation to burtomab for the treatment of pediatric patients with relapsed or refractory neuroblastoma who have central nervous…
CME

Breakthroughs in the Treatment of Bladder Cancer

This activity is supported by an educational grant from Bristol-Myers Squibb.

Assessment of immune checkpoint blockade inhibitors in the treatment of bladder cancer have demonstrated significant…
More »
Video
Meeting News

VIDEO: Visiting expert program helps community providers learn about immuno-oncology

June 12, 2017
More »
Featured
ASCO Annual Meeting

ASCO Annual Meeting

CME

Bridging the Gap from Knowledge to Practice in CRPC

This activity is supported by educational funding provided by AbbVie Inc.; Astellas Scientific and Medical Affairs, Inc. and Medivation; and Sanofi US.

The selection of therapy for patients with castration-resistant prostate cancer (CRPC) remains challenging. Review…
More »

Geneticist to lead Vanderbilt cancer center’s health disparities program

June 19, 2017
Tuya Pal, MD, has been appointed associate director of cancer health disparities at Vanderbilt-Ingram Cancer Center. Pal, a clinical geneticist…

10 highlights from the ASCO Annual Meeting

June 16, 2017
This year’s ASCO Annual Meeting, held June 2-6 in Chicago, featured the theme “Making a Difference in Cancer Care With You.” …

Meeting NewsVideo

VIDEO: Visiting expert program helps community providers learn about immuno-oncology

June 12, 2017
CHICAGO — Jarushka Naidoo, MBBCh, spoke with HemOnc Today at the ASCO Annual Meeting about the Institute for Clinical Immuno-Oncology. The…

FDA News

FDA grants breakthrough therapy designation to burtomab for pediatric neuroblastoma

June 12, 2017
The FDA granted breakthrough therapy designation to burtomab for the treatment of pediatric patients with relapsed or refractory neuroblastoma who…

FDA News

FDA rejects Coherus application for proposed biosimilar to Neulasta

June 12, 2017
The FDA denied approval of Coherus BioSciences’ biologics license application for CHS-1701, a proposed biosimilar for pegfilgrastim. Like…

Lineberger Comprehensive Cancer Center director to lead NCI

June 12, 2017
President Donald J. Trump selected Norman E. “Ned” Sharpless, MD, to serve as director of NCI. Sharpless — recognized for his…

Foundation Medicine announces participation in NCI-MATCH trial

June 7, 2017
Foundation Medicine, NCI and ECOG-ACRIN Cancer Research Group entered a collaboration to evaluate the benefit of genomically guided treatments…

Meeting NewsPerspective

Selumetinib effective for pediatric low-grade glioma

June 5, 2017
CHICAGO — Selumetinib appeared effective and safe for the treatment of recurrent or refractory low-grade glioma in children, according to…

Meeting NewsVideo

VIDEO: Late health problems becoming less common in childhood cancer survivors

June 4, 2017
CHICAGO — Efforts to modify treatments in an attempt to preserve high cure rates while reducing potential late effects have translated to…

Meeting News

CancerLinQ partners with FDA, NCI

June 3, 2017
CHICAGO — ASCO’s big-data initiative CancerLinQ announced a long-term partnership with the FDA to use patient data to evaluate the…

More Headlines »
Advertisement
Advertisement